Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gregory Pharmaceutical Holdings, Inc. (GPH) is a private pharmaceutical holding company based in Bristol, Tennessee. It operates two primary business divisions: UPM Pharmaceuticals, an independent contract development and manufacturing organization (CDMO), and NFI Consumer Products, which markets the Blue-Emu brand of topical products. GPH specializes in the formulation, development, and large-scale manufacturing of oral solid and semi-solid dosage forms, including tablets, capsules, creams, and ointments. The company maintains a significant manufacturing footprint, utilizing a 475,000-square-foot facility acquired from Pfizer to support both its proprietary consumer brands and third-party pharmaceutical clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gregory Pharmaceutical Holdings.